Biogen Inc.
BIIB
Market Cap$20.04B
Volume38.86K
Revenue$10.00B
Gross Profits$7.56B
Employees7605
About
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRID...